New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication

Details for Australian Patent Application No. 2009324643 (hide)

Owner Achillion Pharmaceuticals, Inc.

Inventors Phadke, Avinash; Chen, Dawei; Gadhachanda, Venkat; Hashimoto, Akihiro; Pais, Godwin; Wang, Xiangzhu; Agarwal, Atul; Kim, Ha Young; Li, Shouming; Liu, Cuixian; Zhang, Suoming; Deshpande, Milind

Agent Cullens

Pub. Number AU-A-2009324643

PCT Pub. Number WO2010/068760

Priority 61/121,378 10.12.08 US; 61/226,317 17.07.09 US

Filing date 10 December 2009

Wipo publication date 17 June 2010

International Classifications

C07D 403/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/437 (2006.01)

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/068760 Priority application(s): WO2010/068760

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009324644-4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication

2009324641-Somatic cell-derived pluripotent cells and methods of use therefor